Annual EBIT
-$149.09 M
-$39.01 M-35.43%
December 31, 2023
Summary
- As of February 7, 2025, ADCT annual earnings before interest & taxes is -$149.09 million, with the most recent change of -$39.01 million (-35.43%) on December 31, 2023.
- During the last 3 years, ADCT annual EBIT has risen by +$91.94 million (+38.14%).
- ADCT annual EBIT is now -62.64% below its all-time high of -$91.67 million, reached on December 31, 2017.
Performance
ADCT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$30.50 M
-$7.47 M-32.42%
September 30, 2024
Summary
- As of February 7, 2025, ADCT quarterly earnings before interest & taxes is -$30.50 million, with the most recent change of -$7.47 million (-32.42%) on September 30, 2024.
- Over the past year, ADCT quarterly EBIT has dropped by -$3.54 million (-13.13%).
- ADCT quarterly EBIT is now -511.39% below its all-time high of -$4.99 million, reached on December 31, 2022.
Performance
ADCT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$113.76 M
+$2.08 M+1.80%
September 30, 2024
Summary
- As of February 7, 2025, ADCT TTM earnings before interest & taxes is -$113.76 million, with the most recent change of +$2.08 million (+1.80%) on September 30, 2024.
- Over the past year, ADCT TTM EBIT has increased by +$35.34 million (+23.70%).
- ADCT TTM EBIT is now -389.96% below its all-time high of -$23.22 million, reached on June 30, 2019.
Performance
ADCT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ADCT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.4% | -13.1% | +23.7% |
| 3 y3 years | +38.1% | +34.9% | +51.2% |
| 5 y5 years | -21.3% | +34.9% | +51.2% |
ADCT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.4% | +36.1% | -511.4% | +46.0% | -3.3% | +51.2% |
| 5 y | 5-year | -35.4% | +38.1% | -511.4% | +75.7% | -27.3% | +54.0% |
| alltime | all time | -62.6% | +38.1% | -511.4% | +75.7% | -390.0% | +54.0% |
ADC Therapeutics SA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$30.50 M(+32.4%) | -$113.76 M(-1.8%) |
| Jun 2024 | - | -$23.03 M(-30.7%) | -$115.84 M(-14.3%) |
| Mar 2024 | - | -$33.26 M(+23.4%) | -$135.15 M(-9.4%) |
| Dec 2023 | -$149.09 M(+35.4%) | -$26.96 M(-17.3%) | -$149.09 M(+17.3%) |
| Sep 2023 | - | -$32.59 M(-23.0%) | -$127.12 M(-5.5%) |
| Jun 2023 | - | -$42.34 M(-10.3%) | -$134.50 M(-9.5%) |
| Mar 2023 | - | -$47.20 M(+846.1%) | -$148.67 M(+35.1%) |
| Dec 2022 | -$110.09 M(-52.8%) | -$4.99 M(-87.5%) | -$110.09 M(-27.5%) |
| Sep 2022 | - | -$39.96 M(-29.3%) | -$151.93 M(-15.2%) |
| Jun 2022 | - | -$56.52 M(+556.1%) | -$179.10 M(-6.9%) |
| Mar 2022 | - | -$8.61 M(-81.6%) | -$192.36 M(-17.5%) |
| Dec 2021 | -$233.16 M | -$46.83 M(-30.2%) | -$233.16 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$67.14 M(-3.8%) | -$240.09 M(+25.5%) |
| Jun 2021 | - | -$69.77 M(+41.2%) | -$191.34 M(-22.6%) |
| Mar 2021 | - | -$49.42 M(-8.1%) | -$247.12 M(+2.5%) |
| Dec 2020 | -$241.04 M(+108.2%) | -$53.76 M(+192.3%) | -$241.04 M(+8.4%) |
| Sep 2020 | - | -$18.39 M(-85.4%) | -$222.40 M(-5.4%) |
| Jun 2020 | - | -$125.56 M(+189.7%) | -$235.05 M(+77.1%) |
| Mar 2020 | - | -$43.33 M(+23.4%) | -$132.71 M(+48.5%) |
| Dec 2019 | -$115.75 M(-5.8%) | - | - |
| Dec 2019 | - | -$35.12 M(+13.1%) | -$89.38 M(+64.7%) |
| Sep 2019 | - | -$31.04 M(+33.7%) | -$54.26 M(+133.7%) |
| Jun 2019 | - | -$23.22 M | -$23.22 M |
| Dec 2018 | -$122.87 M(+34.0%) | - | - |
| Dec 2017 | -$91.67 M | - | - |
FAQ
- What is ADC Therapeutics SA annual earnings before interest & taxes?
- What is the all time high annual EBIT for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual EBIT year-on-year change?
- What is ADC Therapeutics SA quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly EBIT year-on-year change?
- What is ADC Therapeutics SA TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ADC Therapeutics SA?
- What is ADC Therapeutics SA TTM EBIT year-on-year change?
What is ADC Therapeutics SA annual earnings before interest & taxes?
The current annual EBIT of ADCT is -$149.09 M
What is the all time high annual EBIT for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual earnings before interest & taxes is -$91.67 M
What is ADC Therapeutics SA annual EBIT year-on-year change?
Over the past year, ADCT annual earnings before interest & taxes has changed by -$39.01 M (-35.43%)
What is ADC Therapeutics SA quarterly earnings before interest & taxes?
The current quarterly EBIT of ADCT is -$30.50 M
What is the all time high quarterly EBIT for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly earnings before interest & taxes is -$4.99 M
What is ADC Therapeutics SA quarterly EBIT year-on-year change?
Over the past year, ADCT quarterly earnings before interest & taxes has changed by -$3.54 M (-13.13%)
What is ADC Therapeutics SA TTM earnings before interest & taxes?
The current TTM EBIT of ADCT is -$113.76 M
What is the all time high TTM EBIT for ADC Therapeutics SA?
ADC Therapeutics SA all-time high TTM earnings before interest & taxes is -$23.22 M
What is ADC Therapeutics SA TTM EBIT year-on-year change?
Over the past year, ADCT TTM earnings before interest & taxes has changed by +$35.34 M (+23.70%)